NL-OMON56737
Not yet recruiting
Not Applicable
ong Term Cardiovascular Disease Event Risk for Patients undergoing Non-Cardiac Surgery. A pilot study. - 10 year CVD event risk in non-cardiac surgical patients
niversity Health Network Toronto0 sites25 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity Health Network Toronto
- Enrollment
- 25
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age 45 \- 75 years
- •2\. Scheduled for intermediate\- to high risk non\-cardiac surgery (intra\-thoracic
- •or intra\-abdominal surgery, all vascular surgery, intra\-cranial neurosurgery,
- •spine surgery)
- •3\. Expected postoperative length of stay of at least two days, according to the
- •surgeon\*s expectation
- •4\. At least two of the following CVD risk factors:
- •o History of: Hypertension, Diabetes, Coronary artery disease, Chronic heart
- •failure, Chronic kidney disease, Cerebrovascular disease, Peripheral vascular
- •o Obesity (BMI \>25 kg/m2\), Current smoking, Poor exercise capacity (\<4 METS)
Exclusion Criteria
- •1\. Currently participating in a CVD risk reduction program
- •2\. Patient is scheduled to undergo transplant or has undergone emergency
- •3\. Life expectancy \<1 year (palliative surgery)
- •4\. Recent (\<6 months) myocardial infarction or stroke
- •5\. Inability to effectively communicate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Investigating the Effect of Plant Based Diets on Cardiovascular Disease RiskACTRN12621000743864niversity of Newcastle240
Not yet recruiting
Not Applicable
Evaluation of heart disease risk in type 2 Diabetes Mellitus patients using FRS, Q-RISK3, INTERHEART Risk Scores & their correlation with lipoprotein (a) level.Health Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2022/08/044536Dr Ramesh Kumar Chandak
Recruiting
Phase 4
A clinical trial for Heart Disease Risk assessment and treatment of patients with high risk.Health Condition 1: I00-I99- Diseases of the circulatory systemCTRI/2019/04/018723Dr Saurabha Nayak
Recruiting
Phase 3
ong term impact of RAS inhibition on cardio-renal outcomes: a comparative trial of angiotensin converting enzyme inhibitors, angiotensin receptor blockers or combined therapy with both agents in patients with one or more cardiovascular risk factors and microalbuminuria, diabetic or not diabetic.Patients with one or more cardiovascular risk factors and microalbuminuria, diabetic or not diabetic.Cardiovascular - Normal development and function of the cardiovascular systemMetabolic and Endocrine - DiabetesACTRN12607000333415Consorzio Mario Negri Sud2,100
Completed
Not Applicable
A cohort of patients with high risk for cardiovascular eventsAtherosclerotic patients.Atherosclerotic risk patients.AtherosclerosisAtheroscleroticCoronary artery diseaseCerebrovascular diseasePeripheral arterial diseaseRisk factorTCTR20130520001The Heart Association of Thailand under the Royal Patronage of H.M.9,390